Glenmark is a global leader in the development and commercialization of generic drugs of the highest quality and value. With more than 70 products currently approved in Europe and many more pending approval, we improve people’s lives every day by helping to reduce their healthcare costs while delivering high-quality medicines.

To find the latest Glenmark SPC and Patient Information Leaflets (PIL) please visit the EMC-website